Regenxbio (RGNX) Debt Ratio (2014)
Regenxbio (RGNX) posted quarterly Debt Ratio of 0.41 for Q4 2014.
Powered by 
Analysis
Regenxbio (RGNX) Debt Ratio (2014) Analysis & Trends
Regenxbio's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.41 for Q4 2014.
- In Q4 2014, Debt Ratio changed N/A year-over-year to 0.41; the TTM figure through Dec 2014 stood at 0.41 (changed N/A YoY), while the FY2014 annual figure was 0.41, changed N/A from the prior year.
- Debt Ratio for Q4 2014 stood at 0.41.
- The five-year high for Debt Ratio was 0.41 in Q4 2014, with the low at 0.41 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.47 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.26 |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - | - |